 |
small molecule inhibitor of Exon 17 Mutant KIT |
|---|---|
| Trade Name | |
| Orphan Indication | Mastocytosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-21 00:00:00 |
| Sponsor | Blueprint Medicines Corporation;38 Sidney Street, Suite 200;Cambridge, Massachusetts, 02139 |
